A $16 Billion Fund's Favorite Healthcare Stocks in Third Quarter Wall St. Cheat Sheet The Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders. Astrazeneca Plc (NYSE:AZN): On 06/30/2011 reported holding ... |
